51ݶ

Online Media Kit

FEATURED STORY

March 16, 2022 | Times LIVE (South Africa)

The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women.

FEATURED STORY

February 26, 2022 | The East African (Kenya)

Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring.

FEATURED STORY

January 26, 2021 | World Health Organization

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as...

Media Highlights

August 31, 2020 | Mpasho News (Kenya)

The Kenya News Agency provides an overview of regulatory progress with the dapivirine ring and completed and ongoing studies.

August 31, 2020 | Microbicide Trials Network

The B-PROTECTED study will assess the safety of the monthly dapivirine ring and daily oral PrEP among women who are breastfeeding, as well as their babies, in Malawi, South Africa, Uganda and...

August 28, 2020 | HIV i-Base (UK)

On 24 July 2020, the EMA adopted a positive opinion for the safety and efficacy of a dapivirine vaginal ring to be used to protect against HIV.

August 27, 2020 | HealthTimes (Zimbabwe)

If approved, the dapivirine ring would expand women's HIV prevention options with a woman-controlled, long-acting tool.

August 24, 2020 | Seronet (France)

The European Medicines Agency issued a positive opinion for the dapivirine ring on Friday, July 24, for countries outside the EU.

Pages